Wei Shang
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 09, 2026
Impact of p16 Status on the Efficacy of Pembrolizumab Combined Nimotuzumab in Recurrent/Unresectable/Metastatic Head and Neck Squamous Cell Carcinoma Patients.Jieying Li, Yueqin Tao, Haoyue Xu
|Jun 09, 2025
Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population.Jieying Li, Kai Zhou, Xiaohong Zhan
|Jun 03, 2025
Chinese Expert Consensus on Management of Betel-Chewing-Related Oral Squamous Cell Carcinoma.Wei Guo, Rongfa Bu, Longjiang Li
|Mar 15, 2025
RAC1 promotes the occurrence and development of tongue squamous cell carcinoma by regulating RAC1/PAK1/LIMK1 signaling pathway.Zongxuan He, Kai Song, Hongyu Han
|Jun 01, 2023
Efficacy and Safety of Pembrolizumab Monotherapy for Recurrent/Unresectable/Metastatic Oral Squamous Cell Carcinoma: A Single-Center Study in China.Jieying Li, Zongxuan He, Yueqin Tao
Pageof 1
